Open AccessIncidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium
Author(s) -
Sapna A. Mehta,
Meenakshi Rana,
Jennifer D. Motter,
Catherine B. Small,
Marcus R. Pereira,
Valentina Stosor,
Nahel Elias,
Brandy Haydel,
Sander Florman,
Jonah Odim,
Megan Morsheimer,
Mark A. Robien,
Allan B. Massie,
Diane Brown,
Brian J. Boyarsky,
Jacqueline Garonzik-Wang,
Aaron A.R. Tobian,
William A Werbel,
Dorry L. Segev,
Christine M. Durand
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000003527
Subject(s) - medicine , immunosuppression , intensive care unit , incidence (geometry) , tocilizumab , cohort , prospective cohort study , immunology , disease , physics , optics
Transplant recipients with HIV may have worse outcomes with coronavirus disease 2019 (COVID-19) due to impaired T-cell function coupled with immunosuppressive drugs. Alternatively, immunosuppression might reduce inflammatory complications and/or antiretrovirals could be protective.